| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.874 |
| Total Income - EUR | 13.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.194 |
| Total Expenses - EUR | 14.433 | 33 | 55 | 129 | 126 | 124 | 101 | 101 | 142 | 5.878 |
| Gross Profit/Loss - EUR | -1.369 | -33 | -55 | -129 | -126 | -124 | -101 | -101 | -142 | 2.316 |
| Net Profit/Loss - EUR | -1.761 | -33 | -55 | -129 | -126 | -124 | -101 | -101 | -142 | 1.924 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Dr. Maniuvet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5 | 16 | 72 | 49 | 27 | 109 | 5 | 5 | 1.077 | 9.182 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.829 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 380 |
| Cash | 5 | 16 | 72 | 49 | 27 | 109 | 5 | 5 | 1.077 | 972 |
| Shareholders Funds | -4.178 | -4.169 | -4.153 | -4.206 | -4.251 | -4.295 | -4.300 | -4.415 | -4.543 | 1.924 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.189 | 4.191 | 4.225 | 4.255 | 4.278 | 4.403 | 4.306 | 4.421 | 5.620 | 7.258 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Dr. Maniuvet S.r.l.